Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01478711 · ClinicalTrials.gov registry record · NA
Comprehensive Clinical Decision Support (CDS) for the Primary Care of Premature Infants
A NA study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 1,517
- Enrollment target
NCT01478711: Completed NA study, sponsored by Children's Hospital of Philadelphia.
NCT01478711 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 1,517 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01478711, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,517 participants
- Enrollment target
Study Summary
This study will use a rules-based expert system embedded in an electronic health record (EHR) to extract, interpret, and present salient facts and recommendations related to the healthcare of premature infants.
Primary Outcome
Design and evaluation of the pre-implementation data-mining and expert system will employ usability methods from the human-computer interaction (HCI) field. The methods are based on the collection of quantitative and qualitative data where each method has specific metric-based goals that are to be achieved before the next phase. 10-20 clinicians, including attending physicians, nurse practitioners and nurses, from a single practice will be recruited to participate in the Usability Study.
Interventions
- OTHER Clinical Decision Support Tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,517 participants |
| Start Date | 2009-09 |
| Est. Completion | 2012-10 |
| Phase | NA |
What the finished NCT01478711 record still lists
NCT01478711 is an interventional study that assigns participants to a tested intervention. Its 1,517 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 1 intervention - of which Clinical Decision Support Tool is the first listed.
NCT01478711 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01478711 about?
NCT01478711 is a clinical study titled "Comprehensive Clinical Decision Support (CDS) for the Primary Care of Premature Infants". This study will use a rules-based expert system embedded in an electronic health record (EHR) to extract, interpret, and present salient facts and recommendations related to the healthcare of premature infants.
What is the current status of trial NCT01478711?
This trial is currently completed. It is a NA study. The enrollment target is 1,517 participants. The study started on 2009-09. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01478711?
The interventions under investigation include: Clinical Decision Support Tool (OTHER).
Who is sponsoring clinical trial NCT01478711?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01478711's enrollment target sits among peer trials
1,517 65th of 2000 higher than 1,936 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07232017 · 1,520 participants
Implementation of Intensive Hypertension Management Approaches: Cleveland Clinic
- NCT05633654 · 1,514 participants · Phase 3
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
- NCT07136623 · 1,513 participants
Detecting Pulmonary Hypertension With the Eko CORE 500 Digital Stethoscope
- NCT06876714 · 1,524 participants · Phase 3
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia